Phytochemical Study and Therapeutic Evaluation of Mudgaparni (Vigna trilobata Linn.) for its Vataraktahara action
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 58
- 试验地点
- 1
- 主要终点
- Serum Uric Acid level less than 6mg/dl will be considered as Healthy individuals
研究概览
简要总结
HYPERURICEMIA IS CHARACTERIZED BY RAISED SERUM URIC ACID LEVEL FOR MALES AND FEMALES 7mg/dl AND 6mg/dl RESPECTIVELY. IN AYURVEDA VATARAKTA IS THE CLINICAL CONDITION WHOSE CLASSICAL FEATURES ARE SHULA, SARUKA SHOTHA, RAGA, KANDU, VIDAHA, SPARSHASAHISHNUTA ALONG WITH ELEVATED SERUM URIC ACID LEVELS. MUDGAPARNI (VIGNA TRILOBATA LINN.) IS DOCUMENTED AS VATARAKTAHARA BY RAJA NIGHANTU AND DHANVANTARI NIGHANTU. HYPERURICEMIA CAN LEAD TO SOME SERIOUS COMPLICATIONS SUCH AS GOUTY ARTHRITIS, NEPHROLITHIASIS ETC. HENCE, MUDGAPARNI AS A SAFE, COST EFFECTIVE, EASILY AVAILABLE AND NUTRITIVE SOLUTION SHOULD BE EXPLORED FOR ITS VATARAKTAHARA ACTION AND AS ANTI-HYPERURICEMIC EFFECT. AS TILL DATE NO STANDARD DRUG IS IDENTIFIED TO PREVENTS RECURRENCE OF HYPERURICEMIA EPISODES.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1 Patient of either sex belong to age group 20-60 years.
- •2 Diagnosed cases of Vatarakta with classical symptoms such as Shula,Saruka shotha, Kandu, Vidaha, Sparshasahishnuta.
- •3 Serum Uric Acid level more than 7mg/dl for Male and more than 6mg/dl for Female.
- •4 Patient willing to participate in Trial and give written informed consent.
排除标准
- •1 Serum Uric Acid level more than 10mg/dl.
- •2 Diagnosed cases of Inflammatory Joint Disorders such as Rheumatoid Arthritis, Osteoartritis, Psoriatic Arthritis.
- •3 Patients suffering from Chronic Renal Impairment, Chronic Respiratory Diseases, Hepatic Disease.
- •4 Pregnant and Lactating patients.
- •6 Patients taking any form of Medication for Hyperuricemia.
结局指标
主要结局
Serum Uric Acid level less than 6mg/dl will be considered as Healthy individuals
时间窗: 3 Months
次要结局
- For Assessing the effectiveness of treatment, the scoring pattern of Subjective & Objective parameters will be assessed before & after treatment(Before & After Completion of Trial)
研究者
Manaswini Singh
Ayurvedic and Unani Tibbia College and Hospital, Karol Bagh, New Delhi